跳至主要内容
临床试验/NCT04261348
NCT04261348Unknown不适用

Effects of an Antimicrobial Stewardship (AMS) Program, on the Prevalence of Multidrug-resistant Gram - Negative Pathogens, in an Area of High Consumption of Antibiotics and High Resistance Rates

Laikο General Hospital, Athens1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2020年2月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
500
试验地点
1
主要终点
Hospital mortality rate

研究概览

简要总结

  1. To evaluate the long-term effect of the AMS program on the consumption of broad-spectrum antibiotics and on the consumption of antibiotics in general (sustainability of the efficacy of the program). More specifically, the investigators shall examine the consumption of protected antibiotics during the years 2019 - 2020 and they shall compare it with the consumption of antibiotics before the implementation of the AMS program.
  2. To evaluate the impact of the AMS program, combined with an infection control program, on the incidence of MDRGN infections in a hospital with high MDR incidence. Confounding factors are a barrier to analyze the impact of ASPs on antibiotic resistance. In a hospital setting, one of the most important confounding factors is the implementation of infection control practices at the same time as the ASPs. It is extremely difficult to infer causality between an ASP and antibiotic resistance reduction when infection control is a confounding factor, especially if the study intervention combines an ASP and infection control practices performed at the same time. The way to go around the problem is to implement ASP and IC at different time points. The investigators implemented the ASP program in September 2015 and they added the IC program in September 2018. Therefore, the investigators shall be able to compare the two-time periods (i.e. ASP alone vs. ASP/IC) by using the time series analysis and delineate the impact of each intervention.
  3. To evaluate the effect of the AMS program on patient outcomes (in-hospital mortality, length of stay)

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Hospital mortality rate

时间窗: 2 years

in-hospital mortality rate (%)

Consumption of antibiotics

时间窗: 2 years

consumption of antimicrobials (defined daily doses / 100 patient-days)

Length of stay

时间窗: 2 years

length of stay (number of days)

Days of antibiotics

时间窗: 2 yars

days of antibiotics (number of days)

Days of therapy

时间窗: 2 years

days of therapy for each drug (number of days)

Patients receiving surgical prophylaxis

时间窗: 2 years

percentage of patients receiving appropriate surgical prophylaxis

Clinical cure rate

时间窗: 2 years

clinical cure rate of the initial antibiotic regimen (%)

次要结局

未报告次要终点

研究者

发起方
Laikο General Hospital, Athens
申办方类型
Other
责任方
Principal Investigator
主要研究者

Nikolaos Sipsas

Professor

Laikο General Hospital, Athens

研究点 (1)

Loading locations...

相似试验